Bonus | Ozempic: Is It Scarier Than We Thought? From Science Vs - podcast episode cover

Bonus | Ozempic: Is It Scarier Than We Thought? From Science Vs

Aug 09, 202439 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

There are a lot of fads, blogs and strong opinions, but then there’s SCIENCE. Science Vs is the show from Gimlet that finds out what’s fact, what’s not, and what’s somewhere in between.


Science VS looked at the class of weight loss drugs called GLP-1 receptor agonists a year ago, and they've only gotten more popular — and more controversial. We’re hearing that these kinds of drugs can be tough on your stomach, and that the weight loss comes with worrisome loss of muscle. We’ve also heard claims that they might increase your risk of suicide. So — should we be freaking out here?? In this episode, Science Vs hosts talk to endocrinologist Dr. Vibha Singhal, neuroscientist Dr. Nora Volkow, and gastroenterologist Dr. Michael Camilleri.  


And a warning, this episode does deal with depression and suicidal thoughts. A full list of international hotlines can be found here. The episode transcript can be found here: https://bit.ly/ScienceVsOzempic2Scarier 

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Bonus | Ozempic: Is It Scarier Than We Thought? From Science Vs | The Dose podcast - Listen or read transcript on Metacast